1-20 of 50
Suryavathi Viswanadhapalli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 648: A novel small molecule targeting oncogenic PELP1 demonstrates anti-tumor activity in wild-type and mutant ER-positive breast cancer

Kristin Ann Altwegg, Monica Mann, Dimple Chakravarty, Zexuan Liu, Junhao Liu, Uday P. Pratap, Behnam Ebrahimi, John R. Sanchez, Ben H. Park, Hariprasad Vankayalapati, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 648.
DOI: https://doi.org/10.1158/1538-7445.AM2022-648
Published: 15 June 2022
View article
Journal Articles

Abstract 891: Therapeutic targeting of ovarian cancer stem cells using estrogen receptor beta agonist

Yi He, Salvador Alejo, Prabhakar P. Venkata, Jessica D. Johnson, Ilanna Loeffel, Julie Ann Martel, Uday P. Pratap, Suryavathi Viswanadhapalli, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Edward Kost, Gangadhara R. Sareddy
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 891.
DOI: https://doi.org/10.1158/1538-7445.AM2022-891
Published: 15 June 2022
View article
Journal Articles

Abstract P5-10-01: Leukemia inhibitory factor receptor inhibition reduces obesity driven progression of triple negative breast cancer

Suryavathi Viswanadhapalli, Uday P Pratap, Behnam Ebrahimi, Logan Blankenship, Jaitri Joshi, Zexuan Liu, Kristin A Altwegg, Xiaonan Li, Gangadhara R Sareddy, Bindu Santhamma, Swapna Konda, Manjeet Rao, Edward Kost, Rajeshwar R Tekmal, Hareesh B Nair, Ratna K Vadlamudi
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-10-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-10-01
Published: 15 February 2022
View article
Journal Articles

Abstract P1-04-11: Pd-l1-expressing b-cells promote murine breast cancer development and mediate the response to anti-pd-l1 immune checkpoint inhibitor

Mustafa Tamim Alam Khan, Christian Cervantes, Suryavathi Viswanadhapalli, Yan Hui, Ratna Vadlamudi, Zhenming Xu
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-04-11.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-04-11
Published: 15 February 2022
View article
Journal Articles

Abstract LB160: PD-L1-expressing B cells promote murine breast cancer development and mediate the response to anti-PD-L1 immune checkpoint inhibitor to upregulate B-cell CD86 and inhibit tumor growth

Mustafa T. Khan, Christian Cervantes, Zexuan Liu, Suryavathi Viswanadhapalli, Harshita Gupta, Tyler Curiel, Ratna Vadlamudi, Zhenming Xu
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB160.
DOI: https://doi.org/10.1158/1538-7445.AM2021-LB160
Published: 01 July 2021
View article
Journal Articles

Abstract 1333: Evaluation of a novel PELP1 inhibitor for treatment of triple negative breast cancer

Kristin A. Altwegg, Suryavathi Viswanadhapalli, Junhao Liu, Zexuan Liu, Uday P. Pratap, Hariprasad Vankayalapati, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1333.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1333
Published: 01 July 2021
View article
Journal Articles

Abstract 733: Significance of PELP1/SETDB1 axis in endocrine therapy resistance

Zexuan Liu, Junhao Liu, Weiwei Tang, Uday P. Pratap, Kristin A. Altwegg, Behnam Ebrahimi, Xiaonan Li, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 733.
DOI: https://doi.org/10.1158/1538-7445.AM2021-733
Published: 01 July 2021
View article
Journal Articles

Abstract 2026: KDM1A inhibition augment ER stress inducers efficacy to reduce glioblastoma stemness

Yi He, Prabhakar Pitta Venkata, Salvador Alejo, Yihong Chen, Bridgitte Palacios, Gabrielle Gray, Uday P. Pratap, Suryavathi Viswanadhapalli, Siyuan Zheng, Rajeshwar R. Tekmal, Andrew J. Brenner, Gangadhara R. Sareddy
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2026.
DOI: https://doi.org/10.1158/1538-7445.AM2021-2026
Published: 01 July 2021
View article
Journal Articles

Abstract 1253: Therapeutic targeting of endometrial cancer with novel LIFR inhibitor EC359

Weiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar M. Pillai, Bindu Santhamma, Swapna Konda, Prabhakar P. Vekata, Logan Blankenship, Junhao Liu, Zexuan Liu, Kristin A. Altwegg, Behnam Ebrahimi, Uday P. Pratap, Xiaonan Li, Edward Kost, Gangadhara R. Sareddy, Ratna K. Vadlamudi, Hareesh B. Nair, Rajeshwar R. Tekmal, Suryavathi Viswanadhapalli
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1253.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1253
Published: 01 July 2021
View article
Journal Articles

Abstract 1237: Preclinical evaluation of ERX-41 in triple negative breast cancer

Suryavathi Viswanadhapalli, Xihui Liu, Shi-Hong Ma, Tae-Kyung Lee, Mengxing Li, Weiwei Tang, Junhao Liu, Xiaonan Li, Gangadhara R. Sareddy, Rajeshwar Rao Tekmal, Jung-Mo Ahn, Ratna K. Vadlamudi, Ganesh V. Raj
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1237.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1237
Published: 01 July 2021
View article
Journal Articles

Abstract PS17-34: Proto-oncogene PELP1 interactions with SETDB1 contribute to aberrant activation of AKT1 in breast cancer

Zexuan Liu, Junhao Liu, Weiwei Tang, Uday P. Pratap, Kristin A. Altwegg, Xiaonan Li, Suryavathi Viswanadhapalli, Ratna Vadlamudi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-34.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS17-34
Published: 15 February 2021
View article
Journal Articles

Abstract PS17-15: Targeting the PELP1 axis for treating ESR1 mutant driven breast cancer

Kristin A Altwegg, Suryavathi Viswanadhapalli, Junhao Liu, Zexuan Liu, Uday P. Pratap, Benham Ebrahimi, Hariprasad Vankayalapati, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-15.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS17-15
Published: 15 February 2021
View article
Journal Articles

Abstract PS17-09: Development of a potent mutant-ESR1 targeted agent, ERX-245, for treating metastatic therapy-resistant breast cancer

Ganesh V Raj, Suryavathi Viswanadhapalli, Karla Parra, Shihong Ma, Tae-Kyung Lee, Xihui Liu, Kara Kassees, Weiwei Tang, Junhao Liu, Zexuan Liu, Uday P Pratap, Behnam Ebrahimi, Rajeshwar Rao Tekmal, Jung-Mo Ann, Ratna K Vadlamudi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS17-09
Published: 15 February 2021
View article
Journal Articles

Abstract PS19-14: Matrin3 inhibits breast cancer growth by suppressing microtubule nucleation protein MZT2B

Panneerdoss Subbarayalu, Subapriya Rajamanickam, Suryavathi Viswanadhapalli, Fuyang Li, Vijay Eedunuri, Pooja Yadav, Esha Reddy, Santosh Timilsina, Saif SR Nirzhor, Benjamin C Onyeagucha, Li-Ju Wang, Yu-Chiao Chiu, Tabrez Mohammad, Nourhan Abdelfattah, Nicholas Dybdal-Hargreaves, Yidong Chen, Ratna Vadlamudi, Manjeet Rao
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS19-14.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS19-14
Published: 15 February 2021
View article
Journal Articles

Abstract 4371: PELP1-TFAP2C crosstalk promotes endocrine resistance in breast cancer cells

Junhao Liu, Suryavathi Viswanadhapalli, Mengxing Li, Uday P. Pratap, Weiwei Tang, Zexuan Liu, Yiliao Luo, Kristin A. Altwegg, Xiaonan Li, Gangadhara R. Sareddy, Rajeshwar R. Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4371.
DOI: https://doi.org/10.1158/1538-7445.AM2020-4371
Published: 15 August 2020
View article
Journal Articles

Abstract 4365: Estrogen receptor β agonists reverses letrozole therapy resistance of breast cancer through FOXO3 and FOXM1 mediated actions

Kumaraguruparan Ramasamy, Suryavathi Viswanadhapalli, M.A. Sureshkumar, Susan Weintraub, Ratna K. Vadlamudi, Rajeshwar R. Tekmal
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4365.
DOI: https://doi.org/10.1158/1538-7445.AM2020-4365
Published: 15 August 2020
View article
Journal Articles

Abstract 4377: HDAC inhibitors enhance ESR2 expression and augment response to ESR2 agonist therapy

Uday P. Pratap, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Weiwei Tang, Prabhakar Pitta Venkata, Junhao Liu, Rajeshwar R. Tekmal, Andrew Brenner, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4377.
DOI: https://doi.org/10.1158/1538-7445.AM2020-4377
Published: 15 August 2020
View article
Journal Articles

Abstract 5676: Preclinical evaluation of estrogen receptor coregulator binding inhibitor ERX-245 in breast cancer

Suryavathi Viswanadhapalli, Shihong Ma, Tae Kyung Lee, Xihui Liu, Kara Kassees, Uday P. Pratap, Junhao Liu, Weiwei Tang, Rajeshwar R. Tekmal, Jung-Mo Ahn, Ganesh V. Raj, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5676.
DOI: https://doi.org/10.1158/1538-7445.AM2020-5676
Published: 15 August 2020
View article
Journal Articles

Abstract 562: Novel combination therapy for treating TNBC using LIFR and HDAC Inhibitors

Suryavathi Viswanadhapalli, Mengxing Li, Bindu Santhamma, Uday P. Pratap, Yiliao Luo, Junhao Liu, Kristin A. Altwegg, Xiaonan Li, Ahmed Gulzar, Hui Yan, Zhenming Xu, Andrew Brenner, Gangadhara R. Sareddy, Manjeet K. Rao, Rajeshwar R. Tekmal, Hareesh B. Nair, Klaus J. Nickisch, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 562.
DOI: https://doi.org/10.1158/1538-7445.AM2020-562
Published: 15 August 2020
View article
Journal Articles

Abstract 6220: KDM1A inhibition sensitizes glioblastoma cells to temozolomide therapy through DNA damage and apoptosis pathway modulation

Bridgitte E. Palacios, Prabhakar Pitta Venkata, Yihong Chen, Salvador Alejo, Yi He, Suryavathi Viswanadhapalli, Uday Pratap, Junhao Liu, Xiaonan Li, Takayoshi Suzuki, Siyuan Zheng, Andrew Brenner, Ratna Vadlamudi, Gangadhara Sareddy
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6220.
DOI: https://doi.org/10.1158/1538-7445.AM2020-6220
Published: 15 August 2020
View article